Michael Wyand serves as Executive at EPIRUS Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael Wyand has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 27, 2016 involved selling 1,379 shares valued at $3.9K.
Michael Wyand currently holds 32,661 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Wyand has been a net neutral trader of EPRS stock. They have purchased $0 and sold $0 worth of shares.
Michael Wyand's most recent insider trade was on Feb 27, 2016, when they sold 1,379 shares at $2.80 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 27, 2016 | EPRS | $0 | Option Exercise | 1,044 | $N/A | Discretionary |
| Feb 27, 2016 | EPRS | $0 | Option Exercise | 2,608 | $N/A | Discretionary |
| Feb 27, 2016 | EPRS | $3.9K | Payment | 1,378 | $2.80 | Discretionary |
| Feb 27, 2016 | EPRS | $0 | Option Exercise | 1,044 | $N/A | Discretionary |
| Sep 14, 2015 | EPRS | $8.7K | Option Exercise | 8,747 | $1.00 | Discretionary |
| Jul 15, 2014 | EPRS | $0 | Award | 21,641 | $N/A | Discretionary |